Strength Across Segments to Help CAH Stock Offset OptumRx Headwind?

Cardinal Health Inc. (CAH) is well-poised for growth, given its acquisition-driven strategy, a diversified product portfolio and a robust pharmaceutical segment. However, inflationary pressure remains a concern.Shares of this Zacks Rank #2 (Buy) company have risen 24.3% in the year-to-date period compared with the industry’s 4.8% gain. The S&P 500 Index has gained 27.1% in the same time frame.         CAH, with a market capitalization of $29.83 billion, is a nationwide drug distributor and service provider ...